The Role of Formal Policy to Promote Informed Consent of Psychotropic Medications for Youth in Child Welfare Custody: A National Examination.
Child Welfare
Classification
Informed Consent by Minors
Legislation as Topic
Psychotropic Drugs
Journal
Administration and policy in mental health
ISSN: 1573-3289
Titre abrégé: Adm Policy Ment Health
Pays: United States
ID NLM: 8914574
Informations de publication
Date de publication:
11 2022
11 2022
Historique:
accepted:
19
07
2022
pubmed:
7
8
2022
medline:
2
11
2022
entrez:
6
8
2022
Statut:
ppublish
Résumé
Active participation of youth and surrogate decision-makers in providing informed consent and assent for mental health treatment is critical. However, the procedural elements of an informed consent process, particularly for youth in child welfare custody, are not well defined. Given calls for psychotropic medication oversight for youth in child welfare custody, this study proposes a taxonomy for the procedural elements of informed consent policies based upon formal and informal child welfare policies and then examines whether enacted state formal policies across the United States endorsed these elements. A sequential multi-method study design included: (1) semi-structured interviews with key informants (n = 58) primarily from state child welfare agencies to identify a taxonomy of procedural elements for informed consent of psychotropic medications and then (2) a legislative review of the 50 states and D.C. to characterize whether formal policies endorsed each procedural element through February 2022. Key informants reported five procedural elements in policy, including how to: (1) gather social and medical history, (2) prescribe the medication, (3) authorize its use through consent and youth assent, (4) notify relevant stakeholders, and (5) routinely review the consenting decision. Twenty-three states endorsed relevant legislation; however, only two states specified all five procedural elements. Additionally, the content of a procedural element, when included, varied substantively across policies. Further research and expert consensus are needed to set best practices and guide policymakers in setting policies to advance transparency and accountability for informed consent of mental health treatment among youth in child welfare custody.
Identifiants
pubmed: 35932357
doi: 10.1007/s10488-022-01212-3
pii: 10.1007/s10488-022-01212-3
pmc: PMC9616785
doi:
Substances chimiques
Psychotropic Drugs
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, N.I.H., Extramural
Langues
eng
Sous-ensembles de citation
IM
Pagination
986-1003Subventions
Organisme : AHRQ HHS
ID : R36 HS021985
Pays : United States
Organisme : AHRQ HHS
ID : R01 HS026001
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR003017
Pays : United States
Informations de copyright
© 2022. The Author(s).
Références
American Academy of Child & Adolescent Psychiatry. (2012). A guide for community child serving agencies on psychotropic medications for children and adolescents. Retrieved from https://www.aacap.org/App_Themes/AACAP/docs/press/guide_for_community_child_serving_agencies_on_psychotropic_medications_for_children_and_adolescents_2012.pdf .
American Academy of Child & Adolescent Psychiatry. (2015). Recommendations about the use of psychotropic medications for children and adolescents involved in ChildServing systems. Retrieved from https://www.aacap.org/App_Themes/AACAP/docs/clinical_practice_center/systems_of_care/AACAP_Psychotropic_Medication_Recommendations_2015_FINAL.pdf .
Barnett, E. R., Boucher, E. A., Neubacher, K., & Carpenter-Song, E. A. (2016a). Decision-making around psychotropic medications for children in foster care: Perspectives from foster parents. Children and Youth Services Review, 70, 206–213.
doi: 10.1016/j.childyouth.2016.09.012
Barnett, E. R., Butcher, R. L., Neubacher, K., Jankowski, M. K., Daviss, W. B., Carluzzo, K. L., Ungarelli, E. G., & Yackley, C. R. (2016b). Psychotropic medications in child welfare: From federal mandate to direct care. Children and Youth Services Review, 66, 9–17. https://doi.org/10.1016/j.childyouth.2016.04.015
doi: 10.1016/j.childyouth.2016.04.015
Barnett, E. R., Concepcion-Zayas, M. T., Zisman-Ilani, Y., & Bellonci, C. (2019). Patient-centered psychiatric care for youth in foster care: A systematic and critical review. Journal of Public Child Welfare, 13(4), 462–489.
doi: 10.1080/15548732.2018.1512933
Bertrand, J. T., Brown, J. E., & Ward, V. M. (1992). Techniques for analyzing focus group data. Evaluation Review, 16(2), 198–209.
doi: 10.1177/0193841X9201600206
Braithwaite, R. S., & Caplan, A. (2014). Does patient-centered care mean that informed consent is necessary for clinical performance measures? Journal of General Internal Medicine, 29(4), 558–559.
doi: 10.1007/s11606-013-2645-4
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3, 77–101.
doi: 10.1191/1478088706qp063oa
Chen, S., Barner, J. C., & Cho, E. (2021). Trends in off-label use of antipsychotic medications among Texas Medicaid children and adolescents from 2013 to 2016. Journal of Managed Care & Specialty Pharmacy, 27(8), 1035–1045.
doi: 10.18553/jmcp.2021.27.8.1035
Child and Family Services Improvement and Innovation Act of 2011, P.L. pp. 112–134. (2011).
Christian, R. B., Farley, J. F., Sheitman, B., et al. (2013). A+KIDS, a web-based antipsychotic registry for North Carolina youth: An alternative to prior authorization. Psychiatric Services, 64(9), 893–900.
doi: 10.1176/appi.ps.002762012
Committee on Quality of Health Care in America, & Institute of Medicine. (2001). Crossing the quality chasm: A new health system for the 21st century. National Academy Press.
Crystal, S., Mackie, T. I., Fenton, M. C., Amin, S., Neese-Todd, S., Olfson, M., & Bilder, S. (2016). Rapid growth of antipsychotic prescriptions for children who are publicly insured has ceased, but concerns remain. Health Affairs, 35(6), 974–982.
doi: 10.1377/hlthaff.2016.0064
Crystal, S., Olfson, M., Huang, C., Pincus, H., & Gerhard, T. (2009). Broadened use of atypical antipsychotics: Safety, effectiveness, and policy challenges. Health Affairs (millwood), 28(5), w770–w781.
doi: 10.1377/hlthaff.28.5.w770
Fostering Connections to Success and Increasing Adoptions Act of 2008, P.L. pp. 110–351. (2008).
Ginsberg, M. D. (2010). Informed consent: no longer just what the doctor ordered-the contributions of medical associations and courts to a more patient friendly doctrine. Michigan State University Journal of Medicine and Law, 15, 17.
Government Accountability Office. (2011). Foster children: HHS guidance could help states improve oversight of psychotropic prescriptions. Retrieved from Washington, DC http://www.gao.gov/new.items/d12270t.pdf .
Government Accountability Office. (2017). Foster children: HHS has taken steps to support states’ oversight of psychotropic medication, but additional assistance could further collaboration. Retrieved from Washington, DC https://www.gao.gov/assets/gao-17-129.pdf .
Hall, D. E., Prochazka, A. V., & Fink, A. S. (2012). Informed consent for clinical treatment. CMAJ, 184(5), 533–540.
doi: 10.1503/cmaj.112120
Hyde, J. K., Mackie, T. I., Palinkas, L. A., Niemi, E., & Leslie, L. K. (2016). Evidence use in mental health policy making for children in foster care. Administration and Policy in Mental Health and Mental Health Services Research, 43(1), 52–66.
doi: 10.1007/s10488-015-0633-1
Katz, A. L., & Webb, S. A. (2016). Informed consent in decision-making in pediatric practice. Pediatrics (evanston), 138(2), e20161485. https://doi.org/10.1542/peds.2016-1485
doi: 10.1542/peds.2016-1485
Lipsky, M. (2010). Street-level bureaucracy: Dilemmas of the individual in public service. Russell Sage Foundation.
Mackie, T. I., Cook, S., Crystal, S., Olfson, M., & Akincigil, A. (2020a). Antipsychotic use among youth in foster care enrolled in a specialized managed care organization intervention. Journal of the American Academy of Child & Adolescent Psychiatry, 59(1), 166–176.
doi: 10.1016/j.jaac.2019.04.022
Mackie, T., Hyde, J., Palinkas, L. A., Niemi, E., & Leslie, L. K. (2017). Fostering psychotropic medication oversight for children in foster care: A national examination of states’ monitoring mechanisms. Administration and Policy in Mental Health and Mental Health Services Research, 44(2), 243–257.
doi: 10.1007/s10488-016-0721-x
Mackie, T. I., Schaefer, A. J., Karpman, H. E., Lee, S. M., Bellonci, C., & Larson, J. (2020b). Systematic review: Systemwide interventions to monitor pediatric antipsychotic prescribing and promote best practice. Journal of the American Academy of Child & Adolescent Psychiatry. https://doi.org/10.1016/j.jaac.2020.08.441
doi: 10.1016/j.jaac.2020.08.441
Mosca, L., Linfante, A. H., Benjamin, E. J., Berra, K., Hayes, S. N., Walsh, B. W., Fabunmi, R. P., Kwan, J., Mills, T., & Simpson, S. L. (2005). National study of physician awareness and adherence to cardiovascular disease prevention guidelines. Circulation, 111(4), 499–510. https://doi.org/10.1161/01.CIR.0000154568.43333.82
doi: 10.1161/01.CIR.0000154568.43333.82
Naylor, M. W., Davidson, C. V., Ortega-Piron, D. J., Bass, A., Gutierrez, A., & Hall, A. (2007). Psychotropic medication management for youth in state care: Consent, oversight, and policy considerations. Child Welfare, 86(5), 175–192.
Noonan, K., & Miller, D. J. H. L. (2013). Fostering transparency: A preliminary review of policy governing psychotropic medications in foster care. Hasting LJ, 65, 1515.
Oppenheim, E., Lee, R., Lichtenstein, C., Bledsoe, K. L., & Fisher, S. K. (2012). Reforming mental health services for children in foster care: The role of child welfare class action lawsuits and systems of care. Families in Society, 93(4), 287–294.
doi: 10.1606/1044-3894.4239
Patton, M. Q. (2002). Qualitative evaluation and research methods (Vol. 3). Sage.
Quinlan-Davidson, M., Roberts, K. J., Devakumar, D., Sawyer, S. M., Cortez, R., & Kiss, L. (2021). Evaluating quality in adolescent mental health services: A systematic review. British Medical Journal Open, 11(5), e044929.
Raghavan, R., Bright, C. L., & Shadoin, A. L. (2008). Toward a policy ecology of implementation of evidence-based practices in public mental health settings. Implementation Science, 3(1), 26. https://doi.org/10.1186/1748-5908-3-26
doi: 10.1186/1748-5908-3-26
Rinfret, S. R., Scheberle, D., & Pautz, M. C. (2018). Public policy: A concise introduction. CQ Press.
Simmel, C., Bowden, C. F., Neese-Todd, S., Hyde, J., & Crystal, S. (2021). Antipsychotic treatment for youth in foster care: Perspectives on improving youths’ experiences in providing informed consent. American Journal of Orthopsychiatry, 91(2), 258.
doi: 10.1037/ort0000532
Srivastava, A., & Thomson, S. B. (2009). Framework analysis: a qualitative methodology for applied policy research.
Substance Abuse and Mental Health Services Administration. (2018). Guidance on strategies to promote best practice in antipsychotic prescribing for children and adolescents. HHS Publication No. PEP19‐ ANTIPSYCHOTIC‐BP. Rockville, MD: Office of Chief Medical Officer.
The Adoption and Safe Families Act of 1997, P.L. pp. 105–189. (1997).